Back
Morphic Holding Vs. Keros Therapeutics Industry Stock Comparison
Buy
62
MORF
Morphic Holding
Last Price:
28.63
Seasonality Move:
27.05%
Sell
13
KROS
Keros Therapeutics
Last Price:
54.31
Seasonality Move:
-7.87%
Buy
62
Morphic Holding (MORF)
is a Buy
Is Morphic Holding a Buy, Sell or Hold?
- The current Morphic Holding [MORF] share price is $28.62. The Score for MORF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- MORF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
13
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $54.27. The Score for KROS is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- KROS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MORF Stock Price Chart
What is Morphic Holding's stock price today?
-
The Morphic Holding share price today is $28.62
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MORF is experiencing slight selling pressure.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $54.27
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.
MORF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.52 | Sell |
| Relative Strength Index (14 RSI): | 43.86 | Sell |
| Chaikin Money Flow: | -70884 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (27.82 - 29.86) | Sell |
| Bollinger Bands (100): | (27.99 - 35.73) | Sell |
KROS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.15 | Sell |
| Relative Strength Index (14 RSI): | 38.38 | Sell |
| Chaikin Money Flow: | -272416 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.98 - 60.8) | Sell |
| Bollinger Bands (100): | (48.68 - 66) | Sell |
MORF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.27 | Sell |
| 20-day SMA: | 28.56 | Buy |
| 50-day SMA: | 31.66 | Sell |
| 200-day SMA: | 33.78 | Sell |
| 8-day EMA: | 29.09 | Sell |
| 20-day EMA: | 29.25 | Sell |
| 50-day EMA: | 30.58 | Sell |
| 200-day EMA: | 33.68 | Sell |
KROS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.07 | Sell |
| 20-day SMA: | 57.56 | Sell |
| 50-day SMA: | 62.34 | Sell |
| 200-day SMA: | 45.13 | Buy |
| 8-day EMA: | 57.41 | Sell |
| 20-day EMA: | 58.37 | Sell |
| 50-day EMA: | 59.23 | Sell |
| 200-day EMA: | 50.61 | Buy |
Morphic Holding Earnings Growth & MORF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.30 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.09 per share, an increase this year of $0.55 per share, and a decrease next year of $0.76 per share.
Morphic Holding Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Keros Therapeutics Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||